Emmanuel S. Antonarakis

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626885

Top 100%

0DataRank

Top 100%0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Papers

Driven by 71 papers — median percentile 0. Top paper: “Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial”.

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02284-w

N/A

3.0DataRank · unranked

106 citations

Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim +19 more

T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3372

N/A

2.7DataRank · unranked

117 citations

Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross +14 more

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

The Prostate(2021)10.1002/pros.24110

N/A

1.7DataRank · unranked

71 citations

Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan +12 more

A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0024

N/A

1.7DataRank · unranked

59 citations

Stephanie Daignault‐Newton, Scott A. Tomlins, Neeraj Agarwal, Przemyslaw Twardowski, Alicia K. Morgans +11 more

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial

Nature Communications(2024)10.1038/s41467-023-44514-2

N/A

1.3DataRank · unranked

49 citations

Mary‐Ellen Taplin, Rahul Aggarwal, Laura A. Sena, Hao Wang, Hanfei Qi +15 more

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.043

N/A

1.2DataRank · unranked

47 citations

Hao Wang, Su J. Lim ScM, Irina Rifkind, Nduku Ngomba, John T. Isaacs +10 more

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

BMC Cancer(2020)10.1186/s12885-020-07000-2

N/A

1.1DataRank · unranked

32 citations

Matthew P. Deek, Ryan Phillips, Robert F. Hobbs, Reem Malek, Noura Radwan +26 more

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer

Modern Pathology(2021)10.1038/s41379-020-00731-4

N/A

0.717DataRank · unranked

118 citations

Harsimar Kaur, Daniela C. Salles, Sanjana Murali, Edward M. Schaeffer, Jerry S. Lanchbury +8 more

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Oncogene(2020)10.1038/s41388-020-01479-6

N/A

0.701DataRank · unranked

106 citations

Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper +10 more

TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations

(2024)10.1093/oncolo/oyae120

N/A

0.687DataRank · unranked

14 citations

Cora N. Sternberg, Hao Wang, Tingchang Wang, Laura Linville, Catherine H. Marshall +5 more

Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer

European Urology(2020)10.1016/j.eururo.2020.06.033

N/A

0.657DataRank · unranked

79 citations

Pedro Isaacsson Velho, Roberto Nussenzveig, Jonathan Chipman, Víctor Sacristán Santos, Stephanie Erickson +9 more

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4476

N/A

0.631DataRank · unranked

66 citations

Wei Fu, Hao Wang, Jong C. Park, Theodore L. DeWeese, Phuoc T. Tran +14 more

Genomic and Clinicopathologic Characterization of ATM -deficient Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0764

N/A

0.564DataRank · unranked

42 citations

Daniela C. Salles, Sanjana Murali, Jessica Hicks, Minh Nguyen, Colin C. Pritchard +8 more

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0225

N/A

0.554DataRank · unranked

18 citations

Marianna Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth I. Heath +18 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471

N/A

0.546DataRank · unranked

37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0.533DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3233

N/A

0.489DataRank · unranked

25 citations

Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, Yamini Gore +8 more

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00797-0

N/A

0.477DataRank · unranked

23 citations

Allison Makovec, Andrew Elliott, Samuel Kellen, John R. Lozada, Ali T. Arafa +19 more

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3017

N/A

0.406DataRank · unranked

14 citations

Siyuan Guo, Joseph J. Park, David M. Nanus, Daniel J. George, Emmanuel S. Antonarakis +8 more

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer

npj Genomic Medicine(2024)10.1038/s41525-024-00392-1

N/A

0.360DataRank · unranked

10 citations

Laura A. Sena, Abderrahman Day, Benjamin Miller, Carly D. Miller, John R. Lozada +12 more

A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0273

N/A

0.345DataRank · unranked

9 citations

Nicholas A. Zorko, Yvette Soignier, Rhett L. Waller, Madison Shackelford, Joshua T. Walker +19 more

Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.011

N/A

0.330DataRank · unranked

8 citations

Wassim Abida, Emmanuel S. Antonarakis, Alan H. Bryce, Elena Castro, Heather H. Cheng +3 more

Mismatch repair–deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade

Molecular Case Studies(2021)10.1101/mcs.a006094

N/A

0.330DataRank · unranked

8 citations

Daniela C. Salles, Elizabeth L. Engle, Qingfeng Zhu, Hanna Tukachinsky, Tamara L. Lotan +2 more

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

European Urology(2025)10.1016/j.eururo.2025.07.011

N/A

0.292DataRank · unranked

6 citations

Siyuan Guo, Bin Luo, Chenxi Yu, Todd P. Knutson, Anna Kobilka +13 more

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes

European Urology Oncology(2025)10.1016/j.euo.2025.01.002

N/A

0.292DataRank · unranked

6 citations

Abuzar Moradi Tuchayi, Soon Khai Low, Ali T. Arafa, Laura Graham, Roman Gulati +15 more

Reimagining Vaccines for Prostate Cancer: Back to the Future

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2257

N/A

0.269DataRank · unranked

5 citations

Emmanuel S. Antonarakis, Eugene Shenderov

Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5087

N/A

0.241DataRank · unranked

4 citations

Benjamin A. Teply, Su Jin Lim, Hao Wang, Shifeng Mao, William Kevin Kelly +10 more

CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01051-z

N/A

0.241DataRank · unranked

4 citations

Ella Boytim, Ava Gustafson, Megan Ludwig, Liangjun Wang, Atef Ali +18 more

Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen Therapy

medRxiv(2022)10.1101/2022.04.26.22274275

N/A

0.241DataRank · unranked

4 citations

Rajendra Kumar, David E. Sanin, Elizabeth A. Thompson, Dina Rosen, Susan L. Dalrymple +20 more

Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes

Journal of Extracellular Vesicles(2025)10.1002/jev2.70176

N/A

0.208DataRank · unranked

3 citations

Ali T. Arafa, Saasha Vinoo, Jason C. Jones, Abderrahman Day, Hannah E. Bergom +8 more

Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2563

N/A

0.208DataRank · unranked

3 citations

Justin H. Hwang, John R. Lozada, Hilary Seifert, Andrew Elliott, Milan Radovich +8 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0.165DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.63

N/A

0.165DataRank · unranked

2 citations

Catherine H. Marshall, Rebeca Lozano, Petros Grivas, Celestia S. Higano, Tamara L. Lotan +11 more

Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer

Oncotarget(2025)10.18632/oncotarget.28758

N/A

0.104DataRank · unranked

1 citations

Ava Gustafson, Allison Makovec, Ella Boytim, Gabriella von Dohlen, David Moline +12 more

RESTORE: A single-arm, open-label phase II trial of bipolar androgen therapy (BAT) in men with metastatic castration resistant prostate cancer (mCRPC)—A comparison of post-abiraterone (Abi) versus post-enzalutamide (Enza) patients (Pts).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5576

N/A

0.104DataRank · unranked

1 citations

Hao Wang, Michael T. Schweizer, Michael A. Carducci, Channing J. Paller, Benjamin A. Teply +5 more

Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626885

Top 100%

0DataRank

Top 100%0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.c.6666732.v2

N/A

0DataRank · unranked

0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

The Oncologist(2020)10.1002/onco.13601

N/A

0DataRank · unranked

58 citations

Julia Fountain, Pedro Isaacsson Velho, Su Jin Lim, Hao Wang, Emily Nizialek +15 more

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

The Prostate(2020)10.1002/pros.23955

N/A

0DataRank · unranked

37 citations

Eugene Shenderov, Mario A. Eisenberger, Sushant K. Kachhap, Drew M. Pardoll, Samuel R. Denmeade +2 more

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.116

N/A

0DataRank · unranked

2 citations

Ryan Phillips, William T. Shi, Su Jin Lim, Emmanuel S. Antonarakis, Steven P. Rowe +15 more

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.184

N/A

0DataRank · unranked

1 citations

Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou +10 more

LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001792

N/A

0DataRank · unranked

115 citations

Matthew D. Tucker, Ramy Sedhom, Eric Schwartz, Jason Zhu, Chester Kao +12 more

AR Splicing Variants and Resistance to AR Targeting Agents

Cancers(2021)10.3390/cancers13112563

N/A

0DataRank · unranked

65 citations

Changxue Lu, Jun Luo, Emmanuel S. Antonarakis, Mayuko Kanayama

TGM4: an immunogenic prostate-restricted antigen

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001649

N/A

0DataRank · unranked

27 citations

Aleksandar Obradović, Thomas R. Nirschl, Laura Crowley, Rodney Macedo, Alexandros Papachristodoulou +13 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

Liquid-biopsy transcriptomic profiling uncovers molecular mediators of resistance to androgen receptor signaling inhibition in lethal prostate cancer

medRxiv(2021)10.1101/2021.11.01.21265757

N/A

0DataRank · unranked

2 citations

Bob Zimmermann, Giuseppe Galletti, Susan Halabi, Ada Gjyrezi, Qian Yang +16 more

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040

N/A

0DataRank · unranked

0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Cancer Research(2022)10.1158/0008-5472.can-22-0985

N/A

0DataRank · unranked

49 citations

Lukasz P. Gondek, Jun Luo, Emmanuel S. Antonarakis, Catherine H. Marshall

Bipolar androgen therapy (BAT): A patient's guide

The Prostate(2022)10.1002/pros.24328

N/A

0DataRank · unranked

27 citations

Emmanuel S. Antonarakis, Mark C. Markowski, Samuel R. Denmeade

Molecular correlates of high B7-H3-expressing metastatic castrate-resistant prostate cancers (mCRPC) via exome, transcriptome, and epigenome analyses.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5045

N/A

0DataRank · unranked

1 citations

Abderrahman Day, Hannah E. Bergom, Sydney Tape, Sylvan C. Baca, Charles J. Ryan +4 more

Familial Clonal Hematopoiesis in a Long Telomere Syndrome

New England Journal of Medicine(2023)10.1056/nejmoa2300503

N/A

0DataRank · unranked

145 citations

Michael G. Tassia, Kristen E. Schratz, Stephanie M. Yan, Zoe L. Cosner, E. McNally +8 more

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression

JCI Insight(2023)10.1172/jci.insight.169868

N/A

0DataRank · unranked

17 citations

Qizhi Zheng, Jessica Hicks, Levent Trabzonlu, Büşra Özbek, Tracy Jones +13 more

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.09.012

N/A

0DataRank · unranked

11 citations

Yidong Chen, Daniel Rabizadeh, Lauren Vera, Changxue Lu, Sarah M. Nielsen +7 more

Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer

Viruses(2023)10.3390/v15040901

N/A

0DataRank · unranked

8 citations

Naohiko Nakamura, Julia Davydova, Emmanuel S. Antonarakis, Masato Yamamoto, Tatyana Gavrikova

MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.20.529259

N/A

0DataRank · unranked

5 citations

Qizhi Zheng, Jessica Hicks, Levent Trabzonlu, Büşra Özbek, Tracy Jones +13 more

Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.199

N/A

0DataRank · unranked

1 citations

Philip Sutera, Ryan Phillips, Mathew Pierre Deek, Noura Radwan, Catherine H. Marshall +15 more

Data from Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer

(2023)10.1158/0008-5472.c.6513589.v1

N/A

0DataRank · unranked

0 citations

Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen +20 more

Data from Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

(2023)10.1158/1078-0432.c.6530555

Top 100%

0DataRank

Top 100%0 citations

Wei Fu, Hao Wang, Jong C. Park, Theodore L. DeWeese, Phuoc T. Tran +14 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1

N/A

0DataRank · unranked

0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2781

N/A

0DataRank · unranked

0 citations

M.L. Zahurek, Adel Mandl, Michelle A. Rudek, Elisabeth I. Heath, Catherine H. Marshall +13 more

Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection

Endocrinology(2024)10.1210/endocr/bqae022

N/A

0DataRank · unranked

23 citations

Kaylee Judith Kamalanathan, Catalina Galeano‐Garces, Badrinath R. Konety, Emmanuel S. Antonarakis, Jayant Parthasarathy +3 more

Pan-Cancer Interrogation of B7-H3 ( CD276 ) as an Actionable Therapeutic Target Across Human Malignancies

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0546

N/A

0DataRank · unranked

23 citations

John R. Lozada, Nicholas A. Zorko, Andrew Elliott, Allison Makovec, Milan Radovich +18 more

Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients

Cancers(2024)10.3390/cancers16244261

N/A

0DataRank · unranked

6 citations

Megan Ludwig, Onur Tuncer, Lily Kollitz, Ava Gustafson, Ella Boytim +11 more

Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases

npj Precision Oncology(2024)10.1038/s41698-024-00713-8

N/A

0DataRank · unranked

6 citations

David Moline, Alec Horrmann, Ella Boytim, Gabrianne Larson, Ali T. Arafa +11 more

Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes

JCI Insight(2024)10.1172/jci.insight.183158

N/A

0DataRank · unranked

5 citations

Ella Boytim, Sean McSweeney, Negar Sadeghipour, Andrew Elliott, Rachel Passow +11 more

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0501

N/A

0DataRank · unranked

14 citations

Andrew Elliott, Mark G. Evans, James Wacker, Kathleen M. Storey, Emily A. Egusa +14 more

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3471

N/A

0DataRank · unranked

11 citations

Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye +18 more

Case Report: Metastatic small bowel adenocarcinoma with DNA mismatch repair deficiency in an organ transplant recipient treated with anti-PD-1 immunotherapy

Frontiers in Oncology(2025)10.3389/fonc.2025.1579364

N/A

0DataRank · unranked

1 citations

Alexander K. Tsai, B. Park, Robben Schat, Richard Spong, Jill Tsai +4 more

Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypes

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.31.667906

N/A

0DataRank · unranked

1 citations

Ali T. Arafa, Saasha Vinoo, Jason C Jones, Abderrahman Day, Hannah E. Bergom +8 more

Effect of elevated expression of LILRB4 and TSC22D3 on survival in lung cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2633

N/A

0DataRank · unranked

0 citations

Tolulope Adeyelu, Wei‐Zen Wei, Andrew Elliott, Gerold Bepler, Ari M. Vanderwalde +5 more

Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626876

N/A

0DataRank · unranked

0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Emmanuel S. Antonarakis

Indexed papers

Top data-sharing exemplar

Papers